XPH holdings
State Street SPDR S&P Pharmaceuticals ETF
Positions
67 stored of 67 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors State Street Navigator Securities Lending Portfolio II | US8574927062 | 857492706 | 8.579% | $36.8M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 2 | Definium Therapeutics Inc | CA24477V1058 | 24477V105 | 3.089% | $13.2M | Equity (common) | Corporate | Canada | USD |
| 3 | MBX Biosciences Inc | US55287L1017 | 55287L101 | 2.718% | $11.6M | Equity (common) | Corporate | United States | USD |
| 4 | Alumis Inc | US0223071020 | 022307102 | 2.141% | $9.2M | Equity (common) | Corporate | United States | USD |
| 5 | AtaiBeckley Inc | US04650F1012 | 04650F101 | 2.127% | $9.1M | Equity (common) | Corporate | United States | USD |
| 6 | Trevi Therapeutics Inc | US89532M1018 | 89532M101 | 2.124% | $9.1M | Equity (common) | Corporate | United States | USD |
| 7 | Enliven Therapeutics Inc | US29337E1029 | 29337E102 | 2.093% | $9.0M | Equity (common) | Corporate | United States | USD |
| 8 | Amylyx Pharmaceuticals Inc | US03237H1014 | 03237H101 | 2.036% | $8.7M | Equity (common) | Corporate | United States | USD |
| 9 | VeraDermics Inc | US9229671048 | 922967104 | 2.018% | $8.6M | Equity (common) | Corporate | United States | USD |
| 10 | Ligand Pharmaceuticals Inc | US53220K5048 | 53220K504 | 1.943% | $8.3M | Equity (common) | Corporate | United States | USD |
| 11 | Nuvation Bio Inc | US67080N1019 | 67080N101 | 1.892% | $8.1M | Equity (common) | Corporate | United States | USD |
| 12 | Edgewise Therapeutics Inc | US28036F1057 | 28036F105 | 1.883% | $8.1M | Equity (common) | Corporate | United States | USD |
| 13 | Nektar Therapeutics | US6402683063 | 640268306 | 1.876% | $8.0M | Equity (common) | Corporate | United States | USD |
| 14 | Liquidia Corp | US53635D2027 | 53635D202 | 1.865% | $8.0M | Equity (common) | Corporate | United States | USD |
| 15 | Maze Therapeutics Inc | US5787841007 | 578784100 | 1.851% | $7.9M | Equity (common) | Corporate | United States | USD |
| 16 | Harrow Inc | US4158581094 | 415858109 | 1.805% | $7.7M | Equity (common) | Corporate | United States | USD |
| 17 | EyePoint Inc | US30233G2093 | 30233G209 | 1.770% | $7.6M | Equity (common) | Corporate | United States | USD |
| 18 | Amneal Pharmaceuticals Inc | US03168L1052 | 03168L105 | 1.724% | $7.4M | Equity (common) | Corporate | United States | USD |
| 19 | Ocular Therapeutix Inc | US67576A1007 | 67576A100 | 1.715% | $7.3M | Equity (common) | Corporate | United States | USD |
| 20 | Corcept Therapeutics Inc | US2183521028 | 218352102 | 1.698% | $7.3M | Equity (common) | Corporate | United States | USD |
| 21 | Crinetics Pharmaceuticals Inc | US22663K1079 | 22663K107 | 1.664% | $7.1M | Equity (common) | Corporate | United States | USD |
| 22 | Pacira BioSciences Inc | US6951271005 | 695127100 | 1.653% | $7.1M | Equity (common) | Corporate | United States | USD |
| 23 | Merck & Co Inc | US58933Y1055 | 58933Y105 | 1.647% | $7.1M | Equity (common) | Corporate | United States | USD |
| 24 | Indivior Pharmaceuticals Inc | US45579U1097 | 45579U109 | 1.644% | $7.0M | Equity (common) | Corporate | United States | USD |
| 25 | Elanco Animal Health Inc | US28414H1032 | 28414H103 | 1.642% | $7.0M | Equity (common) | Corporate | United States | USD |
| 26 | Johnson & Johnson | US4781601046 | 478160104 | 1.625% | $7.0M | Equity (common) | Corporate | United States | USD |
| 27 | Eli Lilly & Co | US5324571083 | 532457108 | 1.612% | $6.9M | Equity (common) | Corporate | United States | USD |
| 28 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | Not reported | 1.601% | $6.9M | Equity (common) | Corporate | Ireland | USD |
| 29 | Collegium Pharmaceutical Inc | US19459J1043 | 19459J104 | 1.587% | $6.8M | Equity (common) | Corporate | United States | USD |
| 30 | Bristol-Myers Squibb Co | US1101221083 | 110122108 | 1.581% | $6.8M | Equity (common) | Corporate | United States | USD |
| 31 | Supernus Pharmaceuticals Inc | US8684591089 | 868459108 | 1.574% | $6.7M | Equity (common) | Corporate | United States | USD |
| 32 | Royalty Pharma PLC | GB00BMVP7Y09 | Not reported | 1.569% | $6.7M | Equity (common) | Corporate | United Kingdom | USD |
| 33 | Tarsus Pharmaceuticals Inc | US87650L1035 | 87650L103 | 1.568% | $6.7M | Equity (common) | Corporate | United States | USD |
| 34 | WaVe Life Sciences Ltd | SG9999014716 | Not reported | 1.566% | $6.7M | Equity (common) | Corporate | Singapore | USD |
| 35 | Harmony Biosciences Holdings Inc | US4131971040 | 413197104 | 1.566% | $6.7M | Equity (common) | Corporate | United States | USD |
| 36 | Organon & Co | US68622V1061 | 68622V106 | 1.544% | $6.6M | Equity (common) | Corporate | United States | USD |
| 37 | ANI Pharmaceuticals Inc | US00182C1036 | 00182C103 | 1.543% | $6.6M | Equity (common) | Corporate | United States | USD |
| 38 | Viatris Inc | US92556V1061 | 92556V106 | 1.537% | $6.6M | Equity (common) | Corporate | United States | USD |
| 39 | Esperion Therapeutics Inc | US29664W1053 | 29664W105 | 1.536% | $6.6M | Equity (common) | Corporate | United States | USD |
| 40 | Axsome Therapeutics Inc | US05464T1043 | 05464T104 | 1.516% | $6.5M | Equity (common) | Corporate | United States | USD |
| 41 | Innoviva Inc | US45781M1018 | 45781M101 | 1.507% | $6.5M | Equity (common) | Corporate | United States | USD |
| 42 | BioAge Labs Inc | US09077V1008 | 09077V100 | 1.500% | $6.4M | Equity (common) | Corporate | United States | USD |
| 43 | Prestige Consumer Healthcare Inc | US74112D1019 | 74112D101 | 1.468% | $6.3M | Equity (common) | Corporate | United States | USD |
| 44 | Rapport Therapeutics Inc | US75383L1026 | 75383L102 | 1.438% | $6.2M | Equity (common) | Corporate | United States | USD |
| 45 | Pfizer Inc | US7170811035 | 717081103 | 1.435% | $6.1M | Equity (common) | Corporate | United States | USD |
| 46 | Omeros Corp | US6821431029 | 682143102 | 1.423% | $6.1M | Equity (common) | Corporate | United States | USD |
| 47 | Perrigo Co PLC | IE00BGH1M568 | Not reported | 1.419% | $6.1M | Equity (common) | Corporate | Ireland | USD |
| 48 | Xeris Biopharma Holdings Inc | US98422E1038 | 98422E103 | 1.393% | $6.0M | Equity (common) | Corporate | United States | USD |
| 49 | Zoetis Inc | US98978V1035 | 98978V103 | 1.349% | $5.8M | Equity (common) | Corporate | United States | USD |
| 50 | Eton Pharmaceuticals Inc | US29772L1089 | 29772L108 | 1.305% | $5.6M | Equity (common) | Corporate | United States | USD |
| 51 | Phibro Animal Health Corp | US71742Q1067 | 71742Q106 | 1.284% | $5.5M | Equity (common) | Corporate | United States | USD |
| 52 | Amphastar Pharmaceuticals Inc | US03209R1032 | 03209R103 | 1.251% | $5.4M | Equity (common) | Corporate | United States | USD |
| 53 | Arvinas Inc | US04335A1051 | 04335A105 | 1.247% | $5.3M | Equity (common) | Corporate | United States | USD |
| 54 | Zevra Therapeutics Inc | US4884452065 | 488445206 | 1.236% | $5.3M | Equity (common) | Corporate | United States | USD |
| 55 | Alto Neuroscience Inc | US02157Q1094 | 02157Q109 | 1.172% | $5.0M | Equity (common) | Corporate | United States | USD |
| 56 | Phathom Pharmaceuticals Inc | US71722W1071 | 71722W107 | 1.063% | $4.6M | Equity (common) | Corporate | United States | USD |
| 57 | Relmada Therapeutics Inc | US75955J4022 | 75955J402 | 1.058% | $4.5M | Equity (common) | Corporate | United States | USD |
| 58 | CorMedix Inc | US21900C3088 | 21900C308 | 1.007% | $4.3M | Equity (common) | Corporate | United States | USD |
| 59 | Septerna Inc | US81734D1046 | 81734D104 | 0.990% | $4.2M | Equity (common) | Corporate | United States | USD |
| 60 | Theravance Biopharma Inc | KYG8807B1068 | Not reported | 0.957% | $4.1M | Equity (common) | Corporate | Cayman Islands | USD |
| 61 | Aclaris Therapeutics Inc | US00461U1051 | 00461U105 | 0.894% | $3.8M | Equity (common) | Corporate | United States | USD |
| 62 | LB Pharmaceuticals Inc | US50180M1080 | 50180M108 | 0.797% | $3.4M | Equity (common) | Corporate | United States | USD |
| 63 | Aquestive Therapeutics Inc | US03843E1047 | 03843E104 | 0.765% | $3.3M | Equity (common) | Corporate | United States | USD |
| 64 | Fulcrum Therapeutics Inc | US3596161097 | 359616109 | 0.690% | $3.0M | Equity (common) | Corporate | United States | USD |
| 65 | Lexicon Pharmaceuticals Inc | US5288723027 | 528872302 | 0.629% | $2.7M | Equity (common) | Corporate | United States | USD |
| 66 | Evolus Inc | US30052C1071 | 30052C107 | 0.527% | $2.3M | Equity (common) | Corporate | United States | USD |
| 67 | State Street Global Advisors State Street Institutional US Government Money Market Fund | US8574927062 | 857492706 | 0.062% | $266K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |